Ancora Advisors, LLC Gsk PLC Transaction History

Ancora Advisors, LLC

$4.06 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$42.05 - $47.77 $54,454 - $61,862	-1,295 Reduced 34.93%	2,412 $105,000
Q1 2022 May 16, 2022	SELL	$40.23 - $47.74 $197,649 - $234,546	-4,913 Reduced 57.0%	3,707 $161,000
Q1 2022 May 13, 2022	BUY	$40.23 - $47.74 $197,649 - $234,546	4,913 Added 132.53%	8,620 $307,000
Q4 2021 Feb 14, 2022	SELL	$38.88 - $45.31 $18,390 - $21,431	-473 Reduced 11.32%	3,707 $163,000
Q3 2021 Nov 15, 2021	SELL	$38.79 - $43.16 $172,227 - $191,630	-4,440 Reduced 51.51%	4,180 $160,000
Q1 2021 May 14, 2021	SELL	$34.27 - $40.01 $6,854 - $8,002	-200 Reduced 2.27%	8,620 $307,000
Q4 2020 Feb 12, 2021	BUY	$34.07 - $39.94 $50,934 - $59,710	1,495 Added 20.41%	8,820 $324,000
Q2 2020 Aug 14, 2020	SELL	$37.87 - $43.58 $37,870 - $43,580	-1,000 Reduced 12.01%	7,325 $298,000
Q1 2020 May 14, 2020	SELL	$32.47 - $48.83 $12,988 - $19,532	-400 Reduced 4.58%	8,325 $315,000
Q3 2019 Nov 14, 2019	SELL	$40.46 - $43.52 $29,495 - $31,726	-729 Reduced 7.71%	8,725 $373,000
Q2 2019 Aug 12, 2019	SELL	$39.4 - $42.7 $422,801 - $458,213	-10,731 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$38.57 - $42.69 $54,383 - $60,192	-1,410 Reduced 11.61%	10,731 $449,000
Q4 2018 Feb 15, 2019	BUY	$37.8 - $42.69 $11,340 - $12,807	300 Added 2.53%	12,141 $464,000
Q3 2018 Nov 13, 2018	SELL	$39.75 - $42.69 $123,225 - $132,339	-3,100 Reduced 20.75%	11,841 $475,000
Q2 2018 Aug 10, 2018	SELL	$39.61 - $42.76 $86,785 - $93,687	-2,191 Reduced 12.79%	14,941 $602,000
Q1 2018 May 15, 2018	BUY	$36.18 - $40.15 $38,386 - $42,599	1,061 Added 6.6%	17,132 $670,000
Q4 2017 Feb 14, 2018	SELL	$35.34 - $41.9 $102,097 - $121,049	-2,889 Reduced 15.24%	16,071 $570,000
Q3 2017 Nov 14, 2017	BUY	$39.44 - $41.55 $747,782 - $787,788	18,960	18,960 $770,000

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ancora Advisors, LLC with notifications on news.

Account